TRIM11 and cervical carcinoma: For example, in cervical cancer, the TRIM11 mRNA’s stability is enhanced by IGF2BP1 depending on m6A modification, which is mediated by METTL14 and accelerates cervical cancer progression by mediating PHLPP ubiquitination [12].